
www.regeneron.com
Preview meta tags from the www.regeneron.com website.
Linked Hostnames
18- 45 links towww.regeneron.com
- 4 links toinvestor.regeneron.com
- 2 links towww.regeneron.ca
- 2 links towww.regeneron.co.jp
- 2 links towww.regeneron.de
- 2 links towww.regeneron.es
- 2 links towww.regeneron.fr
- 2 links towww.regeneron.it
Thumbnail

Search Engine Appearance
https://www.regeneron.com/
Regeneron: Moving Science to Medicine
Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.
Bing
Regeneron: Moving Science to Medicine
https://www.regeneron.com/
Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.
DuckDuckGo
https://www.regeneron.com/
Regeneron: Moving Science to Medicine
Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.
General Meta Tags
7- titleRegeneron | Pushing the Bounds of Science
- descriptionDiscover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.
- robotsindex, follow
- AriaTagSearch|Open Search Bar|Main Navigation|Mobile Menu Toggle|Main Nav Sub Menus|Search|Homepage Hero Content|Play video|Play video|Play video|Play video|Play video|Close|Close|Close|Close|Close|Close
- CoveoMetadata
Open Graph Meta Tags
5- og:urlhttps://www.regeneron.com/
- og:descriptionDiscover how Regeneron (NASDAQ: REGN) uses the power of science to bring new medicines to patients… over and over again.
- og:imagehttps://www.regeneron.com/images/og/Regeneron_Web_OGimage.png
- og:titleRegeneron: Moving Science to Medicine
- og:typewebsite
Link Tags
6- canonicalhttps://www.regeneron.com/
- preconnecthttps://fonts.googleapis.com
- preconnecthttps://fonts.gstatic.com
- stylesheethttps://fonts.googleapis.com/css2?family=Roboto+Condensed:ital,wght@0,400;0,700;1,400;1,700&family=Roboto:ital,wght@0,400;0,500;0,700;1,400;1,500;1,700&family=Barlow+Condensed:wght@900&display=swap
- stylesheet/_content/Kentico.Content.Web.Rcl/Content/Bundles/Public/systemPageComponents.min.css
Links
72- https://careers.regeneron.com
- https://clinicaltrials.regeneron.com
- https://investor.regeneron.com
- https://investor.regeneron.com/news-releases/news-release-details/itepekimab-met-primary-endpoint-one-two-chronic-obstructive
- https://investor.regeneron.com/news-releases/news-release-details/libtayor-cemiplimab-phase-3-data-adjuvant-treatment-post